Wearable Devices raises $3.3M in private placement for AI6 Labs expansion

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights

Wearable Devices Ltd. secured $3.3 million in gross proceeds from a single institutional investor through a private placement priced at $3.285 per share and warrant. The funds are designated for AI6 Labs expansion, Mudra device commercialization, and general corporate needs, with closing expected on August 3, 2026.

powered bylight_fuzz_icon
47046144

*this image is generated using AI for illustrative purposes only.

Wearable Devices Ltd. (NASDAQ: WLDS) announced on July 31, 2026, that it has entered into a securities purchase agreement to raise approximately $3.3 million in gross proceeds through a private placement of ordinary shares and warrants. The transaction involves the sale of 1,000,000 ordinary shares and warrants to purchase up to 1,000,000 additional shares to a single institutional investor at a combined price of $3.285 per share and warrant. This capital infusion is designed to accelerate the company’s strategic focus on AI-powered touchless sensing technologies, specifically funding its AI6 Labs initiatives and the commercialization of its Mudra product line.

The offering was priced at-the-market under Nasdaq rules and above the last closing price. The warrants issued carry an exercise price of $3.16 per share, are exercisable immediately upon issuance, and will expire five years following the date of issuance. A.G.P./Alliance Global Partners is acting as the sole placement agent for the transaction. The closing of the offering is expected to occur on or about August 3, 2026, subject to customary closing conditions.

Offering Component Details
Gross Proceeds $3.3 million
Shares Sold 1,000,000 ordinary shares
Warrants Issued Up to 1,000,000 ordinary shares
Price Per Unit $3.285 (share + warrant)
Warrant Exercise Price $3.16 per share
Warrant Expiry Five years from issuance
Closing Date On or about August 3, 2026

The company stated that net proceeds will be deployed for several key growth initiatives. Primary uses include the continued commercialization of Mudra products, such as the Mudra Band and Mudra Link devices designed for touch-free control of digital systems. Funds will also support the development and manufacturing of next-generation product lines and the advancement of AI6 Labs initiatives within the Physical AI and Robotics vertical. Additionally, the capital may be used for potential strategic transactions, working capital, and other general corporate purposes.

Regulatory Framework

The offer and sale of these securities are being made in reliance on an exemption from registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended, and/or Regulation D promulgated thereunder, along with applicable state securities laws. Consequently, the securities have not been and will not initially be registered under the Securities Act or applicable state securities laws. Pursuant to the securities purchase agreement, Wearable Devices has agreed to file a registration statement with the U.S. Securities and Exchange Commission covering the resale of the ordinary shares and the ordinary shares underlying the common warrants sold in this offering.

Strategic Implications

The influx of capital underscores Wearable Devices’ commitment to scaling its dual-channel business model, which combines direct-to-consumer sales with enterprise licensing. By funding the AI6 Labs ecosystem, the company aims to integrate research, products, and AI breakthroughs to enhance its position in the XR ecosystem. This move allows the firm to address both consumer needs for stylish, functional wearables in gaming and productivity, and enterprise demands for advanced input solutions in immersive environments. The ability to close this transaction quickly with a single institutional investor suggests strong market confidence in the company’s technology roadmap and its proprietary neural input touchless technology.

How might the dilution from issuing 1,000,000 new shares and warrants impact Wearable Devices' earnings per share and shareholder value in the near term?

What specific milestones or revenue targets must the Mudra product line achieve to justify the capital allocation toward its commercialization?

Could the immediate exercisability of the warrants create downward pressure on WLDS stock price if the market price exceeds the $3.16 exercise price shortly after closing?

like20
dislike

J.B.D Innovation demands Wearable Devices board ouster

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights

J.B.D Innovation Ltd. and Victor Tshuva & Co. — Law Offices acquired a 24.82% stake in Wearable Devices Ltd by purchasing 543,361 shares at $1.751 each. The group demands a special meeting by Sept. 22 to replace four directors, citing dilutive financings and board entrenchment. Wearable Devices holds $18.4 million in cash as of Dec. 31, 2025.

powered bylight_fuzz_icon
46723752

*this image is generated using AI for illustrative purposes only.

Investor group J.B.D Innovation Ltd. and Victor Tshuva & Co. — Law Offices has disclosed a 24.82% stake in Wearable Devices Ltd, signaling an immediate push for governance changes at the company. The group purchased 543,361 ordinary shares at an average price of $1.751 per share on July 23, representing a total investment of $951,425. In a demand letter issued on Monday, the investors called for a special shareholder meeting to be held no later than Sept. 22, aiming to amend the company's articles of association, remove four sitting directors, and elect their own nominees.

The demand targets the removal of directors Guy Wagner, Eli Bachar, Ilana Lurie, and Kobbi Nir from the Board of Directors of Wearable Devices. The investor group cited serial dilutive financings, repeated reverse splits, and board entrenchment as primary reasons for seeking control. They have explicitly demanded that the company refrain from further dilution or implementing anti-takeover measures ahead of the upcoming vote.

Financial Position and Stake Details

The disclosure highlights the financial context surrounding the investment. Wearable Devices held roughly $18.4 million in cash as of Dec. 31, 2025. Additionally, the company secured $5.0 million in gross proceeds from an April warrant inducement. The investor group’s acquisition represents a significant minority position, granting them substantial leverage in the proposed governance overhaul.

Metric Value
Shares Purchased 543,361
Average Price Per Share $1.751
Total Investment $951,425
Stake Acquired 24.82%
Purchase Date July 23
Cash Held (Dec. 31, 2025) $18.4 million
Warrant Inducement Proceeds $5.0 million

Governance Demands

The core of the dispute centers on corporate governance and capital structure management. J.B.D Innovation and Victor Tshuva & Co. argue that previous actions by the board, including dilutive financing rounds and reverse stock splits, have harmed shareholder value and entrenched incumbent leadership. By demanding a special meeting before Sept. 22, the group seeks to expedite the replacement of the majority of the board, replacing the four named directors with four of its own nominees.

What the Numbers Show

The investor group’s ability to acquire a nearly 25% stake for under $1 million suggests significant liquidity or valuation pressure on Wearable Devices shares. With $18.4 million in cash and recent $5.0 million in warrant proceeds, the company maintains a positive liquidity position. However, the investors’ specific objection to "serial dilutive financings" indicates that despite available cash, the board may have relied heavily on equity-based funding mechanisms that eroded existing shareholder value. The push to halt further dilution ahead of the vote underscores a strategic attempt to preserve equity value while restructuring leadership.

How might the incumbent board respond to the demand for a special shareholder meeting before the September 22 deadline, and what legal defenses could they employ?

What is the likelihood that Wearable Devices will implement anti-takeover measures or further dilutive financing in the interim period to thwart the investor group's control bid?

If the investor group successfully replaces the board, what strategic shifts can be expected regarding the company's capital structure and future funding mechanisms?

like16
dislike

More News on Wearable Devices Ltd